Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies

Investigational Site Number : 604002, Lima

Investigational Site Number : 056001, Antwerp

Memorial Sloan-Kettering Cancer Center Site Number : 840014, New York

Investigational Site Number : 380002, Torino

Investigational Site Number : 300001, Athens

Investigational Site Number : 246002, Turku

Investigational Site Number : 804004, Vinnytsia

Duke University Medical College Site Number : 840016, Durham

Investigational Site Number : 724004, Madrid

Emory University Site Number : 840009, Atlanta

Investigational Site Number : 724002, Pamplona

Investigational Site Number : 250001, Toulouse

Investigational Site Number : 724001, Salamanca

Vanderbilt University Site Number : 840001, Nashville

Investigational Site Number : 380001, Bologna

Investigational Site Number : 724008, Seville

Investigational Site Number : 250003, Nantes

Investigational Site Number : 724006, Valencia

Karmanos Cancer Center Site Number : 840027, Detroit

Investigational Site Number : 376002, Tel Litwinsky

Medical College of Wisconsin Site Number : 840017, Milwaukee

Investigational Site Number : 792004, Samsun

Mayo Clinic of Rochester Site Number : 840018, Rochester

University of Chicago Site Number : 840010, Chicago

Washington University School of Medicine Site Number : 840013, St Louis

Investigational Site Number : 484001, Monterrey

Investigational Site Number : 250004, Pierre-Bénite

Investigational Site Number : 804002, Zaporizhzhya

Investigational Site Number : 484003, San Luis Potosí City

Mayo Clinic Site Number : 840003, Scottsdale

Investigational Site Number : 376004, Jerusalem

UCSF MS Center Site Number : 840005, San Francisco

Fred Hutchinson Cancer Research Center Site Number : 840012, Seattle

Investigational Site Number : 643002, Moscow

Investigational Site Number : 643001, Petrozavodsk

Investigational Site Number : 643004, Saint Petersburg

Investigational Site Number : 643003, Novosibirsk

Investigational Site Number : 152001, Temuco

The University Of Michigan Site Number : 840022, Ann Arbor

The Cancer Center At Hackensack University Medical Site Number : 840011, Hackensack

University of Cincinnati Site Number : 840004, Cincinnati

Huntsman Cancer Institute at the University of Utah Site Number : 840002, Salt Lake City

Investigational Site Number : 032003, Capital Federal

Investigational Site Number : 032002, Ciudad Autonoma de Buenos Aires

Investigational Site Number : 032001, Ciudad de Buenos Aires

Hospital Mae de Deus Site Number : 076003, Porto Alegre

Hospital de Amor - Hospital do Cancer de Barretos - Fundacao Pio XII Site Number : 076001, Barretos

Clínica São Germano Site Number : 076002, São Paulo

Instituto COI de Educacao e Pesquisa Site Number : 076004, Rio de Janeiro

Investigational Site Number : 246001, Helsinki

Investigational Site Number : 604001, Arequipa

Investigational Site Number : 792001, Istanbul

Investigational Site Number : 724005, Barcelona

Investigational Site Number : 724007, Badalona

Investigational Site Number : 792002, Ankara

Investigational Site Number : 792005, Ankara

Investigational Site Number : 804001, Kyiv

Investigational Site Number : 826002, Southampton

Investigational Site Number : 826001, Nottingham